| Quarter | Holdings | Value, Excl. Options ($000) | Top Holdings | Form Type | Date Filed | Filing ID |
|---|---|---|---|---|---|---|
| Q3 2026 | 46 | 309,256 | DCTH, VSTM, FENC, XERS | 13F-HR | 11/16/2026 | 000162262726000034 |
| Q2 2026 | 35 | 266,234 | DCTH, FENC, XERS, SVRA | 13F-HR | 8/14/2026 | 000162262726000022 |
| Q1 2026 | 38 | 244,077 | DCTH, XERS, FENC, SVRA | 13F-HR | 5/14/2026 | 000162262726000015 |
| Q4 2025 | 42 | 274,464 | DCTH, SVRA, FENC, XERS | 13F-HR | 2/12/2026 | 000162262726000011 |
| Q3 2025 | 39 | 282,974 | DCTH, CYTK, FENC, VSTM | 13F-HR | 11/13/2025 | 000162262725000038 |
| Q2 2025 | 37 | 206,646 | DCTH, FENC, CYTK, OCUL | 13F-HR | 8/14/2025 | 000162262725000028 |
| Q1 2025 | 34 | 205,230 | DCTH, VSTM, XERS, MYO | 13F-HR | 5/14/2025 | 000162262725000027 |
| Q4 2024 | 40 | 185,657 | DCTH, MYO, MDWD, CMRX | RESTATEMENT | 2/14/2025 | 000162262725000016 |
| Q3 2024 | 33 | 150,727 | DCTH, MYO, CRMD, ABEO | 13F-HR | 10/30/2024 | 000162262724000058 |
| Q2 2024 | 40 | 126,460 | DCTH, MYO, MDWD, OPTN | 13F-HR | 7/12/2024 | 000162262724000045 |
| Q1 2024 | 34 | 106,941 | MYO, LYRA, MDWD, OPTN | 13F-HR | 4/25/2024 | 000162262724000021 |
| Q4 2023 | 30 | 119,521 | LYRA, MYO, ATXS, XERS | 13F-HR | 2/14/2024 | 000162262724000005 |
Each security where the latest filing since 12/18/2024 is a 13D, newest first.
| Issuer | % of Class | Filed | |||
|---|---|---|---|---|---|
|
Neuraxis, INC
13D/A
NRXS · 64134X201
|
9.9% |
11/16/2026
Event 9/30/2026
|
|||
| Rosalind Advisors, Inc. | 9.9% | ||||
| Salamon Steven A J | 9.9% | ||||
| Aharon Gil | 9.9% | ||||
| Rosalind Master Fund L.P. | 9.9% | ||||
|
Delcath Systems, Inc.
13D/A
DCTH · 24661P807
|
9.9% |
10/19/2026
Event 10/13/2026
|
|||
| Rosalind Advisors, Inc. | 9.9% | ||||
| Salamon Steven A J | 9.9% | ||||
| Aharon Gil | 9.9% | ||||
| Rosalind Master Fund L.P. | 4.5% | ||||
| Rosalind Opportunities Fund I L.P. | 4.9% | ||||
14 other securities where the latest filing is a 13G, the newest filed 11/13/2026. View all